1-2 of 2
Arturo Galvani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases

Gianpaolo Fogliatto, Laura Gianellini, Maria G. Brasca, Elena Casale, Dario Ballinari, Marina Ciomei, Anna Degrassi, Anna De Ponti, Massimiliano Germani, Marco Guanci, Mauro Paolucci, Paolo Polucci, Micaela Russo, Francesco Sola, Barbara Valsasina, Carlo Visco, Fabio Zuccotto, Daniele Donati, Eduard Felder, Enrico Pesenti, Arturo Galvani, Sergio Mantegani, Antonella Isacchi
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (13): 3520–3532.
https://doi.org/10.1158/1078-0432.CCR-12-3512
Published: 30 June 2013
View article titled, NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases
Open the PDF for NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases in another window
Includes: Supplementary data
Journal Articles

Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma

Andrea Sartore-Bianchi, Fabio Gasparri, Arturo Galvani, Linda Nici, James W. Darnowski, Dario Barbone, Dean A. Fennell, Giovanni Gaudino, Camillo Porta, Luciano Mutti
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5942–5951.
https://doi.org/10.1158/1078-0432.CCR-07-0536
Published: 01 October 2007
View article titled, Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent <em>In vivo</em> Activity in Mesothelioma
Open the PDF for Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent <em>In vivo</em> Activity in Mesothelioma in another window